ESPR - Esperion Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.13B
Enterprise Value 3980.7M
Trailing P/E N/A
Forward P/E 1-21.39
PEG Ratio (5 yr expected) 1-0.45
Price/Sales (ttm)N/A
Price/Book (mrq)14.29
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-4.80

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-60.70%
Return on Equity (ttm)-124.65%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -204.32M
Net Income Avi to Common (ttm)-201.81M
Diluted EPS (ttm)-7.54
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)136.02M
Total Cash Per Share (mrq)5.07
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.22
Book Value Per Share (mrq)2.95

Cash Flow Statement

Operating Cash Flow (ttm)-148.64M
Levered Free Cash Flow (ttm)-74.46M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.84
52-Week Change 3-42.71%
S&P500 52-Week Change 37.11%
52 Week High 379.30
52 Week Low 333.06
50-Day Moving Average 346.25
200-Day Moving Average 346.76

Share Statistics

Avg Vol (3 month) 3583.5k
Avg Vol (10 day) 3707.1k
Shares Outstanding 526.82M
Float 20.09M
% Held by Insiders 15.05%
% Held by Institutions 1108.02%
Shares Short (Feb 28, 2019) 44.96M
Short Ratio (Feb 28, 2019) 413.02
Short % of Float (Feb 28, 2019) 420.44%
Short % of Shares Outstanding (Feb 28, 2019) 418.49%
Shares Short (prior month Jan 31, 2019) 45.51M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 26/1
Last Split Date 3Jun 11, 2013